2022-04-012023-03-312023-03-31false10511061EAST PARADE DENTAL PRACTICE LIMITED2024-01-30iso4217:GBPxbrli:pure105110612022-04-01105110612023-03-31105110612022-04-012023-03-31105110612021-04-01105110612022-03-31105110612021-04-012022-03-3110511061bus:SmallEntities2022-04-012023-03-3110511061bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3110511061bus:FullAccounts2022-04-012023-03-3110511061bus:PrivateLimitedCompanyLtd2022-04-012023-03-3110511061core:WithinOneYear2023-03-3110511061core:AfterOneYear2023-03-3110511061core:WithinOneYear2022-03-3110511061core:AfterOneYear2022-03-3110511061core:ShareCapital2023-03-3110511061core:SharePremium2023-03-3110511061core:RevaluationReserve2023-03-3110511061core:OtherReservesSubtotal2023-03-3110511061core:RetainedEarningsAccumulatedLosses2023-03-3110511061core:ShareCapital2022-03-3110511061core:SharePremium2022-03-3110511061core:RevaluationReserve2022-03-3110511061core:OtherReservesSubtotal2022-03-3110511061core:RetainedEarningsAccumulatedLosses2022-03-3110511061core:LandBuildings2023-03-3110511061core:PlantMachinery2023-03-3110511061core:Vehicles2023-03-3110511061core:FurnitureFittings2023-03-3110511061core:OfficeEquipment2023-03-3110511061core:NetGoodwill2023-03-3110511061core:IntangibleAssetsOtherThanGoodwill2023-03-3110511061core:ListedExchangeTraded2023-03-3110511061core:UnlistedNon-exchangeTraded2023-03-3110511061core:LandBuildings2022-03-3110511061core:PlantMachinery2022-03-3110511061core:Vehicles2022-03-3110511061core:FurnitureFittings2022-03-3110511061core:OfficeEquipment2022-03-3110511061core:NetGoodwill2022-03-3110511061core:IntangibleAssetsOtherThanGoodwill2022-03-3110511061core:ListedExchangeTraded2022-03-3110511061core:UnlistedNon-exchangeTraded2022-03-3110511061core:LandBuildings2022-04-012023-03-3110511061core:PlantMachinery2022-04-012023-03-3110511061core:Vehicles2022-04-012023-03-3110511061core:FurnitureFittings2022-04-012023-03-3110511061core:OfficeEquipment2022-04-012023-03-3110511061core:NetGoodwill2022-04-012023-03-3110511061core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3110511061core:ListedExchangeTraded2022-04-012023-03-3110511061core:UnlistedNon-exchangeTraded2022-04-012023-03-3110511061core:MoreThanFiveYears2022-04-012023-03-3110511061core:Non-currentFinancialInstruments2023-03-3110511061core:Non-currentFinancialInstruments2022-03-3110511061dpl:CostSales2022-04-012023-03-3110511061dpl:DistributionCosts2022-04-012023-03-3110511061core:LandBuildings2022-04-012023-03-3110511061core:PlantMachinery2022-04-012023-03-3110511061core:Vehicles2022-04-012023-03-3110511061core:FurnitureFittings2022-04-012023-03-3110511061core:OfficeEquipment2022-04-012023-03-3110511061dpl:AdministrativeExpenses2022-04-012023-03-3110511061core:NetGoodwill2022-04-012023-03-3110511061core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3110511061dpl:GroupUndertakings2022-04-012023-03-3110511061dpl:ParticipatingInterests2022-04-012023-03-3110511061dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3110511061core:ListedExchangeTraded2022-04-012023-03-3110511061dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3110511061core:UnlistedNon-exchangeTraded2022-04-012023-03-3110511061dpl:CostSales2021-04-012022-03-3110511061dpl:DistributionCosts2021-04-012022-03-3110511061core:LandBuildings2021-04-012022-03-3110511061core:PlantMachinery2021-04-012022-03-3110511061core:Vehicles2021-04-012022-03-3110511061core:FurnitureFittings2021-04-012022-03-3110511061core:OfficeEquipment2021-04-012022-03-3110511061dpl:AdministrativeExpenses2021-04-012022-03-3110511061core:NetGoodwill2021-04-012022-03-3110511061core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3110511061dpl:GroupUndertakings2021-04-012022-03-3110511061dpl:ParticipatingInterests2021-04-012022-03-3110511061dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3110511061core:ListedExchangeTraded2021-04-012022-03-3110511061dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3110511061core:UnlistedNon-exchangeTraded2021-04-012022-03-3110511061core:NetGoodwill2023-03-3110511061core:IntangibleAssetsOtherThanGoodwill2023-03-3110511061core:LandBuildings2023-03-3110511061core:PlantMachinery2023-03-3110511061core:Vehicles2023-03-3110511061core:FurnitureFittings2023-03-3110511061core:OfficeEquipment2023-03-3110511061core:AfterOneYear2023-03-3110511061core:WithinOneYear2023-03-3110511061core:ListedExchangeTraded2023-03-3110511061core:UnlistedNon-exchangeTraded2023-03-3110511061core:ShareCapital2023-03-3110511061core:SharePremium2023-03-3110511061core:RevaluationReserve2023-03-3110511061core:OtherReservesSubtotal2023-03-3110511061core:RetainedEarningsAccumulatedLosses2023-03-3110511061core:NetGoodwill2022-03-3110511061core:IntangibleAssetsOtherThanGoodwill2022-03-3110511061core:LandBuildings2022-03-3110511061core:PlantMachinery2022-03-3110511061core:Vehicles2022-03-3110511061core:FurnitureFittings2022-03-3110511061core:OfficeEquipment2022-03-3110511061core:AfterOneYear2022-03-3110511061core:WithinOneYear2022-03-3110511061core:ListedExchangeTraded2022-03-3110511061core:UnlistedNon-exchangeTraded2022-03-3110511061core:ShareCapital2022-03-3110511061core:SharePremium2022-03-3110511061core:RevaluationReserve2022-03-3110511061core:OtherReservesSubtotal2022-03-3110511061core:RetainedEarningsAccumulatedLosses2022-03-3110511061core:NetGoodwill2021-04-0110511061core:IntangibleAssetsOtherThanGoodwill2021-04-0110511061core:LandBuildings2021-04-0110511061core:PlantMachinery2021-04-0110511061core:Vehicles2021-04-0110511061core:FurnitureFittings2021-04-0110511061core:OfficeEquipment2021-04-0110511061core:AfterOneYear2021-04-0110511061core:WithinOneYear2021-04-0110511061core:ListedExchangeTraded2021-04-0110511061core:UnlistedNon-exchangeTraded2021-04-0110511061core:ShareCapital2021-04-0110511061core:SharePremium2021-04-0110511061core:RevaluationReserve2021-04-0110511061core:OtherReservesSubtotal2021-04-0110511061core:RetainedEarningsAccumulatedLosses2021-04-0110511061core:AfterOneYear2022-04-012023-03-3110511061core:WithinOneYear2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3110511061core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3110511061core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3110511061core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3110511061core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3110511061core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3110511061core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3110511061core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3110511061core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3110511061core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3110511061core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3110511061core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3110511061core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3110511061core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3110511061core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3110511061core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3110511061core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3110511061core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3110511061core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3110511061bus:Director12022-04-012023-03-3110511061bus:Director22022-04-012023-03-31

EAST PARADE DENTAL PRACTICE LIMITED

Registered Number
10511061
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

EAST PARADE DENTAL PRACTICE LIMITED
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

KUMAR, Gursharon
KUMAR, Kishore

Registered Address

143 Adel Lane
Leeds
LS16 8BW

Registered Number

10511061 (England and Wales)
EAST PARADE DENTAL PRACTICE LIMITED
Statement of Financial Position
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets111,206143,305
Tangible assets24,21043,289
135,416186,594
Current assets
Stocks71,0007,500
Debtors8189,848140,861
Cash at bank and on hand222,143225,966
412,991374,327
Creditors amounts falling due within one year9(123,974)(122,798)
Net current assets (liabilities)289,017251,529
Total assets less current liabilities424,433438,123
Creditors amounts falling due after one year10(326,529)(383,646)
Provisions for liabilities12(4,600)(8,225)
Net assets93,30446,252
Capital and reserves
Called up share capital100100
Profit and loss account93,20446,152
Shareholders' funds93,30446,252
The financial statements were approved and authorised for issue by the Board of Directors on 30 January 2024, and are signed on its behalf by:
KUMAR, Gursharon
Director
KUMAR, Kishore
Director

Registered Company No. 10511061
EAST PARADE DENTAL PRACTICE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company during the year was dentistry.
4.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Intangible assets policy
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed to not exceed ten years. Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows: Goodwill - 10% Straight line If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
The revenue show in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year-end date is recognised by reference to the stage of completion.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Leases policy
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
Going concern
Following the challenges arising as a consequence of the Covid-19 pandemic in 2020/21, more latterly the UK economy has been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company’s trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it, and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
5.Employee information

20232022
Average number of employees during the year20
6.Description of nature of transactions and balances with related parties
The directors loan account is overdrawn by £49,158.48.
7.Stocks

2023

2022

££
Other stocks1,0007,500
Total1,0007,500
8.Debtors

2023

2022

££
Trade debtors / trade receivables12,28221,837
Other debtors177,566119,024
Total189,848140,861
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
9.Creditors within one year

2023

2022

££
Bank borrowings and overdrafts34,29734,276
Taxation and social security52,89056,077
Finance lease and HP contracts21,19019,933
Accrued liabilities and deferred income15,59712,512
Total123,974122,798
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
10.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts299,655335,582
Other creditors26,87448,064
Total326,529383,646
11.Finance lease and HP contracts after one year

2023

2022

££
Finance lease and HP contracts26,87448,064
12.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)4,6008,225
Total4,6008,225